XML 36 R25.htm IDEA: XBRL DOCUMENT v3.24.0.1

Organization and Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2023

Accounting Policies [Abstract]

Schedule of Prior-year Adjustment

The correction to the accompanying consolidated balance sheets, consolidated statements of operations, consolidated statements of comprehensive loss, consolidated statements of stockholders' equity, and consolidated statements of cash flows are as follows (in thousands):

												At December 31, 2022
Consolidated Balance Sheets												As Reported			Adjustment			As Corrected
Goodwill												$	39,775			7,592		$	47,367
Total assets												$	513,376			7,592		$	520,968
Other long-term liabilities												$	11,543			5,546		$	17,089
Accumulated other comprehensive loss												$	(10,690	)		(104	)	$	(10,794	)
Accumulated deficit												$	(934,474	)		2,150		$	(932,324	)
Total stockholders' deficit												$	(36,713	)		2,046		$	(34,667	)
Total liabilities and stockholders' deficit												$	513,376			7,592		$	520,968
		Year Ended December 31, 2022										Year Ended December 31, 2021
Consolidated Statements of Operations		As Reported			Adjustment			As Corrected				As Reported			Adjustment			As Corrected
Income tax provision (benefit)		$	140			(856	)	$	(716	)		$	164			(1,294	)	$	(1,130	)
Net loss		$	(152,149	)		856		$	(151,293	)		$	(144,326	)		1,294		$	(143,032	)
Net loss per share, basic and diluted		$	(1.47	)	$	0.01		$	(1.46	)		$	(1.50	)	$	0.01		$	(1.49	)
		Year Ended December 31, 2022										Year Ended December 31, 2021
Consolidated Statements of Comprehensive Loss		As Reported			Adjustment			As Corrected				As Reported			Adjustment			As Corrected
Net loss		$	(152,149	)		856		$	(151,293	)		$	(144,326	)		1,294		$	(143,032	)
Foreign currency translation adjustments		$	(4,696	)		(62	)	$	(4,758	)		$	(7,198	)		(42	)	$	(7,240	)
Comprehensive loss		$	(156,845	)		794		$	(156,051	)		$	(151,524	)		1,252		$	(150,272	)
		At December 31, 2022										At December 31, 2021
Consolidated Statements of Stockholders' (Deficit) Equity		As Reported			Adjustment			As Corrected				As Reported			Adjustment			As Corrected
Foreign currency translation adjustments		$	(4,696	)		(62	)	$	(4,758	)		$	(7,198	)		(42	)	$	(7,240	)
Net loss		$	(152,149	)		856		$	(151,293	)		$	(144,326	)		1,294		$	(143,032	)
Accumulated other comprehensive loss		$	(10,690	)		(104	)	$	(10,794	)		$	(5,994	)		(42	)	$	(6,036	)
Accumulated deficit		$	(934,474	)		2,150		$	(932,324	)		$	(782,325	)		1,294		$	(781,031	)
Total stockholders' (deficit) equity		$	(36,713	)		2,046		$	(34,667	)		$	79,422			1,252		$	80,674
		Year Ended December 31, 2022										Year Ended December 31, 2021
Consolidated Statements of Cash Flows		As Reported			Adjustment			As Corrected				As Reported			Adjustment			As Corrected
Net loss		$	(152,149	)		856		$	(151,293	)		$	(144,326	)		1,294		$	(143,032	)
Other long-term liabilities		$	(2,342	)		(847	)	$	(3,189	)		$	4,852			(1,179	)	$	3,673
Net cash used for operating activities		$	(75,143	)		9		$	(75,134	)		$	(73,432	)		115		$	(73,317	)
Effect of exchange rate changes on cash		$	(357	)		(9	)	$	(366	)		$	(1,289	)		(115	)	$	(1,404	)

Computation of Basic and Diluted Loss Per Share

The following table sets forth the computation of basic and diluted loss per share (in thousands, except per share data):

		Year Ended December 31,
		2023				2022				2021
Numerator:
Net loss		$	(186,638	)		$	(151,293	)		$	(143,032	)
Denominator:
Weighted average common shares outstanding			121,242				103,373				96,197
Net loss per share, basic and diluted		$	(1.54	)		$	(1.46	)		$	(1.49	)

Anti-Dilutive Securities of Common Stock Excluded from Calculation of Diluted Net Loss Per Share

The following potentially dilutive shares of common stock were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive for the years presented (in thousands):

		Year Ended December 31,
		2023				2022				2021
Series A convertible preferred stock			—				—				29
Options to purchase common stock and employee stock purchase plan			2,555				2,991				3,416
Unvested restricted stock units			7,713				8,533				8,703
Warrants to purchase common stock			8,219				15,491				20,184
Senior convertible notes			17,246				17,246				17,246
			35,733				44,261				49,578

X

- References

No definition available.

+ Details

Name:	us-gaap_AccountingPoliciesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-8

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-7

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483443/250-10-50-9

+ Details

Name:	us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration